Suomen Terveystalo Oy ("Terveystalo"), has renewed its health checks and integrated Nightingale Health's blood analysis technology into regular health checks in occupational health. The renewal has come into effect for Terveystalo's occupational health customers throughout Finland. Terveystalo has the exclusivity to act as Nightingale Health's private healthcare provider partner in Finland.

Nightingale Health and Terveystalo announced in August 2023 that Terveystalo is adopting Nightingale Health's blood Analysis technology in regular health checks in occupational health; The parties have worked together the past months to integrate Nightingale Health's disease risk assessments and diagnostic blood values into the daily work of Terveystalo's occupational Health doctors, nurses, and laboratories. Nightingale Health has built a logistics network and result delivery capability to serve Terveystalo locations across Finland, covering 1,200 kilometers while securing a turnaround time that adheres to healthcare response times. Terveystalo is Finland's largest occupational health service provider, and it offers occupational health services to more than 27,000 companies and other organizations.

Its occupational health services cover approximately 700,000 employees, a significant proportion of Finland's total workforce. Terveystalo provides health and well-being services at over 370 clinics across Finland. Nightingale Health's blood biomarker-based risk assessments can detect disease risks for several common chronic diseases from a single blood sample with a single test.

The renewed health check offered by Terveystalo covers the following eight common chronic diseases: myocardial infarction; cardiovascular disease; type 2 diabetes; liver fibrosis and cirrhosis; chronic kidney disease; COPD; lung cancer; andalcohol liver disease.